Literature DB >> 30167890

Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation.

Mengyuan Zhang1,2, Jianhua He1, Wenli Zhang1, Jianping Liu3.   

Abstract

PURPOSE: In this study, a new modified nanoprecipitation approach that more efficient and simpler than conventional approach was developed to synthesize D-alpha-Tocopheryl polyethylene glycol 1000 succinate stabilized liposome-PLGA hybrid nanoparticle, loaded with simvastatin (ST-TLPN).
METHODS: The optimum formulation was screened via investigation of the impact of TPGS mass within polymeric core and lipid shell on the physicochemical properties of nanoparticles respectively. FTIR, and drug release of ST-TLPN were also systematically determined. Finally, the cellular internalization was evaluated using the murine macrophage cell line, in vivo pharmacokinetic behavior and antiatherogenic efficacies were elaborately examined in atherosclerotic rabbit models.
RESULTS: With the weight ratio of TPGS-to-PLGA in organic phase of 30% and TPGS-to-lipid in aqueous phase of 35%, ST-TLPN exhibited core-shell structure, sub-100 nm size, EE% of over 90% and a slow release profile. The excellent cellular uptake was displayed in RAW264.7 cell line. Improved pharmacokinetic behavior, and enhanced antiatherogenic efficacy of ST-TLPN in the model animals were also revealed compared with ST-loaded PLGA nanoparticles.
CONCLUSION: These findings suggest the modified nanoprecipitation method holds great potential for fabricating LPN, aided by the multiple functions of TPGS. And the prepared TLPN is a promising delivery system for use in the pharmaceutical field.

Entities:  

Keywords:  D-alpha-Tocopheryl polyethylene glycol 1000 succinate; antiatherogenic efficacies; liposome-PLGA hybrid nanoparticle; modified nanoprecipitation approach

Mesh:

Substances:

Year:  2018        PMID: 30167890     DOI: 10.1007/s11095-018-2485-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  33 in total

1.  Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.

Authors:  Hu Yang; Puneet Tyagi; Rajendra S Kadam; Christopher A Holden; Uday B Kompella
Journal:  ACS Nano       Date:  2012-08-21       Impact factor: 15.881

2.  Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.

Authors:  Huijun Zhu; Hongbo Chen; Xiaowei Zeng; Zhongyuan Wang; Xudong Zhang; Yanping Wu; Yongfeng Gao; Jinxie Zhang; Kewei Liu; Ranyi Liu; Lintao Cai; Lin Mei; Si-Shen Feng
Journal:  Biomaterials       Date:  2013-12-19       Impact factor: 12.479

3.  Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.

Authors:  Bo Dong; Cheng Zhang; Jing Bo Feng; Yu Xia Zhao; Shu Ying Li; Ya Pei Yang; Qiu Li Dong; Bi Ping Deng; Li Zhu; Qing Tao Yu; Chun Xi Liu; Bin Liu; Chun Ming Pan; Huai Dong Song; Ming Xiang Zhang; Yun Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-10       Impact factor: 8.311

4.  Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.

Authors:  Guoying Wang; Bo Yu; Yuequn Wu; Baolin Huang; Yuan Yuan; Chang Sheng Liu
Journal:  Int J Pharm       Date:  2013-02-10       Impact factor: 5.875

5.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

Authors:  Liangfang Zhang; Juliana M Chan; Frank X Gu; June-Wha Rhee; Andrew Z Wang; Aleksandar F Radovic-Moreno; Frank Alexis; Robert Langer; Omid C Farokhzad
Journal:  ACS Nano       Date:  2008-08       Impact factor: 15.881

6.  Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation.

Authors:  Jinli Li; Xudong Cheng; Yan Chen; Weiming He; Li Ni; Peihua Xiong; Minggang Wei
Journal:  Int J Pharm       Date:  2016-08-18       Impact factor: 5.875

7.  Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.

Authors:  Lisha Liu; Hongliang He; Mengyuan Zhang; Shuangshuang Zhang; Wenli Zhang; Jianping Liu
Journal:  Biomaterials       Date:  2014-06-16       Impact factor: 12.479

8.  Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin.

Authors:  Tiechuang Wang; Xiaodong Yin; Yaping Lu; Weiguang Shan; Subin Xiong
Journal:  Int J Nanomedicine       Date:  2012-05-08

9.  A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.

Authors:  Raphaël Duivenvoorden; Jun Tang; David P Cormode; Aneta J Mieszawska; David Izquierdo-Garcia; Canturk Ozcan; Maarten J Otten; Neeha Zaidi; Mark E Lobatto; Sarian M van Rijs; Bram Priem; Emma L Kuan; Catherine Martel; Bernd Hewing; Hendrik Sager; Matthias Nahrendorf; Gwendalyn J Randolph; Erik S G Stroes; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 10.  Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.

Authors:  Conglian Yang; Tingting Wu; Yan Qi; Zhiping Zhang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more
  4 in total

1.  D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.

Authors:  Xi Tan; Yan Fang; Yuanyuan Ren; Yinghuan Li; Peicheng Wu; Xiangliang Yang; Wei Liu
Journal:  Int J Nanomedicine       Date:  2019-02-18

2.  Co-Delivery of Dexamethasone and Captopril by α8 Integrin Antibodies Modified Liposome-PLGA Nanoparticle Hybrids for Targeted Anti-Inflammatory/Anti-Fibrosis Therapy of Glomerulonephritis.

Authors:  Liuting Zhou; Zhenyan Ye; E Zhang; Li Chen; Yitong Hou; JuChun Lin; Fenglan Huang; Zhixiang Yuan
Journal:  Int J Nanomedicine       Date:  2022-03-30

Review 3.  Therapeutic lipid-coated hybrid nanoparticles against bacterial infections.

Authors:  Lai Jiang; Hiang Wee Lee; Say Chye Joachim Loo
Journal:  RSC Adv       Date:  2020-02-27       Impact factor: 4.036

4.  Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid).

Authors:  Nathaly S Heredia; Karla Vizuete; Marco Flores-Calero; Katherine Pazmiño V; Fernanda Pilaquinga; Brajesh Kumar; Alexis Debut
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.